PDCD1 and neoplasm: Thus, through specific guidance of PD-1, PD-1/IL-2α-bias can selectively stimulate and expand T cells expressing both PD-1 and IL-2Rα within the tumor, leading to more precise and effective targeting and activation of this T cell subpopulation.